Skip to content
Odvykání kouření

Lecba Odvykání kouření

Prozkoumejte dostupnou lecbu odvykání kouření. Vse zahrnuje posouzeni nezavislym lekarem z EU, originalni leky z licencovanych lekaren a diskretni expresni doruceni.

2026-04-12 Léčba

Interested in Odvykání kouření?

Complete a confidential health assessment reviewed by an independent EU-registered doctor.

Start Assessment

Smoking cessation léčba v Evropě

Tobacco smoking remains the leading preventable cause of death and disease in the European Union. According to WHO data, tobacco kills approximately 700,000 people in the EU each year. The health consequences of smoking are well-established: it is causally linked to lung cancer, chronic obstructive pulmonary disease (COPD), cardiovascular disease, stroke, and numerous other serious conditions. Despite widespread awareness of these risks, nicotine dependence is a recognised chronic relapsing disorder that makes cessation profoundly difficult without appropriate support.

Nicotine acts on reward pathways in the brain, producing dependence through both physical and psychological mechanisms. When a smoker attempts to quit, withdrawal symptoms — including cravings, irritability, anxiety, difficulty concentrating, and disturbed sleep — can be severe and are a primary driver of relapse. This is why the World Health Organization classifies tobacco dependence as a medical condition warranting treatment.

Clinical evidence consistently demonstrates that the combination of pharmacological support and behavioural counselling produces the highest cessation rates. The EMA has approved two prescription medications specifically for smoking cessation: varenicline (sold under the brand name Champix) and bupropion (originally an antidepressant, repurposed for smoking cessation). Nicotine replacement therapy (NRT) — available in patch, gum, lozenge, inhaler, and nasal spray formulations — provides another effective option for reducing withdrawal symptoms.

Access to evidence-based smoking cessation support through a qualified medical professional can significantly improve the chances of a successful and sustained quit attempt.

Dostupné léčby

The following medications may be available for smoking cessation through EU-registered doctors. This comparison is provided for informational purposes only.

MedicationActive IngredientClassTypical Course Duration
Varenicline (Champix)VareniclineNicotinic receptor partial agonist12 weeks (extendable to 24)
BupropionBupropion HClAtypical antidepressant (NDRI)7–9 weeks
Nicotine replacement therapyNicotineNRT (patch, gum, lozenge, inhaler)8–12 weeks

Key distinctions:

  • Varenicline (Champix): Considered the most effective single pharmacotherapy for smoking cessation in clinical trials, with quit rates approximately three times higher than placebo at 12 months. Taken as a standard tablet twice daily after an initial titration period. Not suitable for adolescents under 18.
  • Bupropion: An atypical antidepressant with dopamine and noradrenaline reuptake inhibition activity. Supports cessation by reducing cravings and withdrawal. Important contraindications include seizure history and eating disorders.
  • Nicotine replacement therapy: Reduces withdrawal symptoms by providing nicotine without tobacco combustion products. Over-the-counter formulations are available without prescription; higher-dose or combination NRT may be discussed with a doctor.

Jak získat léčba online

Prescrivia působí jako technologický zprostředkovatel: nepředepisujeme léky, nezaměstnáváme lékaře ani neprodáváme léky. Naše platforma spojuje pacienty s nezávislými lékaři registrovanými v EU, kteří mohou provádět důvěrná online zdravotní posouzení.

Postup je následující:

  1. Vyplňte zdravotní dotazník — Answer a structured set of medical questions covering your smoking history, nicotine dependence level, previous quit attempts, current medications, mental health history, and relevant medical conditions.

  2. Independent doctor review — An independent EU-registered doctor reviews your assessment. If a prescription smoking cessation medication is clinically appropriate, the doctor may issue a prescription. If contraindications are identified, the doctor will advise on alternative options.

  3. Předpis a vyřízení — If a prescription is issued, it is passed to a licensed EU pharmacy partner. The medication is dispensed and delivered to your address.

Důležité: Prescrivia nezaručuje, že bude předpis vystaven. Veškerá rozhodnutí o předepisování provádějí nezávisle kvalifikovaní odborní lékaři na základě Vašich individuálních klinických okolností.

Jak se srovnáváme

Prostřednictvím PrescriviaOsobní návštěva u lékaře
Dostupnost24/7 online assessmentSubject to appointment availability
Čekací dobaAssessment reviewed within hoursDays to weeks depending on location
Cestování nutnéNoYes
Rozhodnutí o předpisuMade by independent EU-registered doctorMade by your GP
Ongoing monitoringSupported via follow-up assessmentsManaged by your GP
NákladyTransparent pricing displayed upfrontVaries by country and healthcare system

Note: Smokers with complex psychiatric histories, those taking multiple medications with significant interaction profiles, or pregnant women should seek in-person consultation for smoking cessation support. Prescrivia’s platform complements but does not replace comprehensive quit programmes that include behavioural support.

Zdroje

Lékařské informace na této stránce vycházejí z následujících zdrojů:

  • European Medicines Agency (EMA). Champix (varenicline) — Summary of Product Characteristics. Available at: ema.europa.eu
  • World Health Organization (WHO). Tobacco — Key facts. who.int
  • Cahill K, et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013.

Tento obsah je pravidelně přezkoumáván s ohledem na aktualizované klinické pokyny. Je poskytován pouze pro informační účely a nepředstavuje lékařské poradenství. Vždy se poraďte s kvalifikovaným zdravotnickým pracovníkem o radě týkající se Vašich individuálních zdravotních okolností.

Frequently asked questions

Mohu získat Odvykání kouření online v Evropě?
Přístup k přípravku můžete získat prostřednictvím online zprostředkovatelských platforem, které Vás spojí s nezávislými lékaři registrovanými v EU. Po vyplnění důvěrného zdravotního dotazníku lékař posoudí, zda je lék pro Vás klinicky vhodný.
Jak funguje Odvykání kouření?
Varenicline is a partial agonist of nicotinic acetylcholine receptors. It reduces cravings by partially stimulating nicotine receptors in the brain, and reduces the rewarding effects of smoking by blocking nicotine from fully binding to those receptors. Clinical trials demonstrate significantly higher quit rates compared to placebo and comparable or superior efficacy to bupropion.
Je bezpečné for everyone?
Bupropion is contraindicated in patients with a history of seizures, eating disorders, bipolar disorder, or those taking monoamine oxidase inhibitors (MAOIs). It also has interactions with various other medications. A thorough medical assessment is essential before it is prescribed. The reviewing doctor will evaluate your full health profile.
Do I need prescription medication to stop smoking?
Not necessarily. Many people successfully quit using over-the-counter nicotine replacement therapy (NRT) — patches, gum, lozenges, and inhalers — without prescription medication. However, prescription medications such as varenicline and bupropion have demonstrated higher cessation rates in clinical trials and may be appropriate for those who have not succeeded with NRT alone or who have a high level of nicotine dependence.
Jak dlouho does a course of smoking cessation medication typically last?
The standard treatment duration for varenicline is 12 weeks, with an optional additional 12-week course to further consolidate abstinence. Bupropion treatment is typically 7–9 weeks. Nicotine replacement therapy is generally used for 8–12 weeks, though duration may be extended based on individual need.
Prescrivia je pouze zprostředkovatelská platforma. Neposkytujeme lékařské služby, nepředepisujeme léčbu ani nevydáváme léky. Všechna lékařská rozhodnutí činí nezávislí lékaři registrovaní v EU. Všechny léky vydávají licencované lékárny v EU. Tato platforma usnadňuje spojení mezi pacienty a poskytovateli zdravotní péče.

Written by Prescrivia Editorial. Medical information sourced from European Medicines Agency (EMA), World Health Organization (WHO), and published clinical data.

This content is informational only and does not constitute medical advice.

Last updated:

Jste připraveni začít?

Vyplňte důvěrné zdravotní hodnocení za přibližně 3 minuty.